(4) Investigations of the roles of APR246 (TP53 modulator) and of magrolimab (anti-CD47 monoclonal antibody enhancing the macrophage-mediated phagocytosis) in TP53-mutated AML. Here, TP53 is linked to acute myeloid leukemia.